Cite
APA Citation
Moroney, J., Yeku, O., Fleming, G., Emens, L., Vaena, D., Dumbrava, E., Rasco, D., Sharma, M., Papadopoulos, K., Patnaik, A., Sullivan, R., Adewoye, H., Ophir, E., Cojocaru, G., Ferre, P., Izar, B., & Gaillard, S. (n.d.). 158P Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant OVCA. Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172068928.0x000005